In the head-to-head STEP 8 trial, semaglutide 2.4 mg produced 15.8% weight loss compared with 6.4% for liraglutide 3.0 mg over the same 68-week period
GLP-1 analogue, exendin-4, modulates MAPKs activity but not the heat shock response in human HepG2 cells
The most common adverse events are gastrointestinal, including nausea, vomiting, diarrhea, constipation, and abdominal pain or stomach pain
You should always talk with your healthcare provider before you change how much you take
you're just recording what happened so you can see patterns later
Shenoy, adding that other explanations for your muscle pain should be explored if youre still experiencing it several weeks after stopping Ozempic